Anna Wajs-Krygowska

Krakow, MA, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Associations between gut microbiota characteristics and non-motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients.

Associations between gut microbiota characteristics and non-motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients.

Journal: Neurogastroenterology and motility

Published: August 28, 2023

Cathepsin B p.Gly284Val Variant in Parkinson's Disease Pathogenesis.

Cathepsin B p.Gly284Val Variant in Parkinson's Disease Pathogenesis.

Journal: International journal of molecular sciences

Published: April 23, 2022

Validation of the Polish version of the Unified Dyskinesia Rating Scale (UDysRS).

Validation of the Polish version of the Unified Dyskinesia Rating Scale (UDysRS).

Journal: Neurologia i neurochirurgia polska

Published: November 03, 2020

Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe.

Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe.

Journal: Parkinsonism & related disorders

Published: October 20, 2020

Validation of the Polish version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).

Validation of the Polish version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).

Journal: Neurologia i neurochirurgia polska

Published: April 15, 2020

Assessments of plasma acyl-ghrelin levels in Parkinson's disease patients treated with deep brain stimulation.

Assessments of plasma acyl-ghrelin levels in Parkinson's disease patients treated with deep brain stimulation.

Journal: Peptides

Published: November 21, 2019

Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.

Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.

Journal: Brain and behavior

Published: October 19, 2018

Activities of Daily Living and Their Relationship to Health-Related Quality of Life in Patients with Parkinson Disease After Subthalamic Nucleus Deep Brain Stimulation.

Activities of Daily Living and Their Relationship to Health-Related Quality of Life in Patients with Parkinson Disease After Subthalamic Nucleus Deep Brain Stimulation.

Journal: World neurosurgery

Published: August 29, 2018

Evaluation of heart rate and blood pressure variability in Parkinson's disease patients after bilateral subthalamic deep brain stimulation

Evaluation of heart rate and blood pressure variability in Parkinson's disease patients after bilateral subthalamic deep brain stimulation

Journal: Przeglad lekarski

Published: January 29, 2016

The effect of subthalamic deep brain stimulation on gastric motility in Parkinson's disease.

The effect of subthalamic deep brain stimulation on gastric motility in Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: December 01, 2015

Acute treatment with doxorubicin induced neurochemical impairment of the function of dopamine system in rat brain structures.

Acute treatment with doxorubicin induced neurochemical impairment of the function of dopamine system in rat brain structures.

Journal: Pharmacological reports : PR

Published: November 12, 2015

Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.

Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.

Journal: The Lancet. Neurology

Published: July 01, 2015

Showing 1-12 of 29

Last Updated: 09/26/2026